Keywords: Prostate, Prostate
Motivation: Quantitative tools may improve PCa diagnosis
Goal(s): The purpose of this study is to evaluate the effectiveness of an automated HM-MRI-based tool to prospectively identify targets before MR-US fusion biopsy in comparison with PIRADS based evaluation by expert radiologists.
Approach: Patients underwent 3T mpMRI along with HM-MRI. Patients received 12-core TRUS-guided sextant random biopsy. Additional biopsy targets selected by radiologist (≥PI-RADS 3) and suspected PCa based on HM-MRI were biopsied, using a Uronav MR-US fusion biopsy device.
Results: The diagnostic performance of HM-MRI for diagnosing clinically significant cancers (≥Gleason 3+4), was either higher than, or on par with that of mpMRI.
Impact: HM-MRI provides automated, quantitative image interpretation, standardized image acquisition, and reproducible results that improves MR-US fusion biopsy by providing more reliable detection of csPCa compared to PIRADS based evaluation by expert radiologists and potentially reduce the number of unnecessary biopsies.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords